Anbio Biotechnology Class A Ordinary Shares (NNNN) vs Sionna Therapeutics, Inc. (SION)

A side-by-side comparison of Anbio Biotechnology Class A Ordinary Shares and Sionna Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Anbio Biotechnology Class A Ordinary Shares logo
NNNN
Anbio Biotechnology Class A Ordinary Shares
$215M
$4.90HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Sionna Therapeutics, Inc. logo
SION
Sionna Therapeutics, Inc.
$214M
$4.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NNNN vs SION

growth of $100 · dividends reinvested · last 2y
NNNN -16.3% (-8.5%/yr)SION -75.7% (-50.7%/yr)NNNN compounded faster over this window
0200400600800Start $1002026$84$24
NNNN SION

NNNN vs SION: by the numbers

  • •NNNN is the larger company ($215M vs $214M market cap).
  • •NNNN is profitable (74.06% net margin) while SION runs a net loss (0.00%).

Metrics side by side

Valuation

MetricNNNNSION
P/B ratio7.130.81

Profitability

MetricNNNNSION
Gross margin87.24%0.00%
Operating margin66.70%0.00%
Net margin74.06%0.00%
ROE21.24%-36.64%
ROIC19.13%-40.18%

Frequently asked

Is NNNN or SION more profitable?
NNNN runs the higher net margin — NNNN at 74.06% versus SION at 0.00%.

Go deeper

Full NNNN analysisFull SION analysisInteractive comparison tool

Dig into the metrics

Anbio Biotechnology Class A Ordinary Shares ROESionna Therapeutics ROEAnbio Biotechnology Class A Ordinary Shares operating marginSionna Therapeutics operating marginAnbio Biotechnology Class A Ordinary Shares revenue growthSionna Therapeutics revenue growthAnbio Biotechnology Class A Ordinary Shares free cash flowSionna Therapeutics free cash flow

Anbio Biotechnology Class A Ordinary Shares & Sionna Therapeutics appear in these rankings

Highest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.